Peregrine Pharmaceuticals reported $26.06M in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US $ 4554M 143M
Biocryst Pharmaceuticals BCRX:US $ 23.38M 7.23M
Bristol Myers Squibb BMY:US $ 2142M 38M
ChemoCentryx CCXI:US 5.47M 2.58M
Eli Lilly And LLY:US $ 3899.4M 6.4M
GlaxoSmithKline GSK:LN 4664M 1339M
Intrexon XON:US $ 0.22M 12.51M
Karyopharm Therapeutics KPTI:US $ 3.47M 404K
Macrogenics MGNX:US $ 2.95M 1.65M
Mannkind MNKD:US $ 20.57M 12.53M
Novartis NOVN:VX SF 6880M 117M
Novavax NVAX:US $ 256.3M 256.3M
Peregrine Pharmaceuticals PPHM:US $ 26.06M 5.01M
Repligen RGEN:US $ 239.12M 25.34M